Opendata, web and dolomites

CURE SIGNED

Constructing a ‘Eubiosis Reinstatement Therapy’ for Asthma

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CURE project word cloud

Explore the words cloud of the CURE project. It provides you a very rough idea of what is the project "CURE" about.

fine    despite    reaching    naturally    deaths    grossly    adding    inflammatory    presentation    asthmatic    tuned    reveal    infections    calls    infection    cure    asthma    eubiosis    untangling    pathophysiology    feasible    clinical    levels    relatively    dysbiotic    indicate    disease    expression    preparations    humans    never    deviations    dysbiosis    reinstating    mixtures    unexplored    microbiome    interactions    generally    western    appearing    efforts    phages    upper    data    imbalanced    bacterial    viruses    symptom    treatment    phage    atopic    close    patients    world    dysregulation    candidates    burden    characteristically    ecology    imposes    strategy    vitro    health    predictive    virus    notwithstanding    bacteriophages    model    attacks    susceptibility    hospitalisations    suboptimal    acute    interface    airway    immune    interventions    microbe    follow    huge    innovation    persistence    pandemic    treatments    abundance    allergy    therapy    validated    populations    countries    respiratory    initiation    infect    airways    rebalancing    predict    appropriate    host    tool    unacceptably    disruptive   

Project "CURE" data sheet

The following table provides information about the project.

Coordinator
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON 

Organization address
address: 6 CHRISTOU LADA STR
city: ATHINA
postcode: 10561
website: www.elke.uoa.gr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Greece [EL]
 Project website https://www.cureasthma.eu
 Total cost 2˙971˙750 €
 EC max contribution 2˙971˙750 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-1-2016-2017
 Funding Scheme RIA
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2021-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON EL (ATHINA) coordinator 353˙750.00
2    THE UNIVERSITY OF MANCHESTER UK (MANCHESTER) participant 1˙128˙000.00
3    SCHWEIZERISCHES FORSCHUNGSINSTITUT FUER HOCHGEBIRGSKLIMA UND MEDIZIN IN DAVOS CH (DAVOS PLATZ) participant 287˙500.00
4    UNIVERSYTET MEDYCZNY W LODZI. PL (LODZ) participant 232˙500.00
5    GIORGI ELIAVA INSTITUTE OF BACTERIOPHAGY, MICROBIOLOGY AND VIROLOGY GE (TBILISI) participant 222˙500.00
6    IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON EL (ATHINA) participant 222˙500.00
7    UMEA UNIVERSITET SE (UMEA) participant 217˙500.00
8    MARIOS LYMARAKIS KAI SIA EE EL (GERAKAS ATTIKI) participant 135˙000.00
9    EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING BE (Brussels) participant 112˙500.00
10    ELIAVA BIO PREPARATIONS LTD GE (TBILISI) participant 60˙000.00

Map

 Project objective

The asthma pandemic imposes a huge burden on patients and health systems in both developed and developing countries. Notwithstanding major efforts in untangling its pathophysiology, we are not even close to reaching a cure. Despite available treatments, symptom control is generally suboptimal and hospitalisations and deaths remain at unacceptably high levels. This calls for disruptive innovation towards a long-term treatment strategy. Asthma is an inflammatory condition associated with immune deviations, most often atopic allergy. However, a key characteristic of asthma that remains relatively unexplored is susceptibility to infection. Most acute asthma attacks follow upper respiratory infections; infections are also associated with asthma initiation and persistence. Recent studies reveal that the respiratory microbiome is characteristically imbalanced (dysbiotic) in asthma. Our own data indicate that a feature of dysbiosis in asthma is reduced abundance of bacteriophages (phages). These bacterial viruses infect and are able to naturally control bacterial populations. Phage therapy has been grossly neglected in the western world and is currently just appearing as a novel tool against infection. However, it has never been used for rebalancing dysbiosis in humans. We propose that reinstating eubiosis within the asthmatic airway through phage therapy is feasible and will be able to control the immune dysregulation and clinical presentation of the disease. To achieve this, we must be able to predict the effects of adding phage mixtures to the complex ecology of the airways and design appropriate interventions. In CURE, we will develop a predictive model using information from virus-bacterial interactions, host responses and clinical disease expression, validated and fine-tuned using an in-vitro host-microbe-phage interface system. The project will develop phage preparations as candidates for clinical testing in asthma

 Deliverables

List of deliverables.
Website and logo Websites, patent fillings, videos etc. 2019-05-31 10:20:03
Variability in space & time Documents, reports 2019-05-31 10:20:01
Data Management Plan Documents, reports 2019-05-31 10:20:04

Take a look to the deliverables list in detail:  detailed list of CURE deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Evangelos Andreakos, Ivan Zanoni, Ioanna E Galani
Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control
published pages: 67-75, ISSN: 0952-7915, DOI: 10.1016/j.coi.2018.10.007
Current Opinion in Immunology 56 2019-04-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CURE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CURE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

RSENSE (2020)

Revolutionizing disease and environmental detection with portable optoacoustic sensing

Read More  

COMMER-CELL (2019)

Commercialisation of neuronal cell co-cultures

Read More  

SCAFFOLD-NEEDS (2019)

Commercialization of 3D scaffold platforms for neuronal cell culture models

Read More